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ABSTRACT The Jun a 3 protein from mountain cedar (Juniperus ashei) pollen, a member of group 5 of the family of plant
pathogenesis-related proteins (PR-proteins), reacts with serum IgE from patients with cedar hypersensitivity. We used the
crystal structures of two other proteins of this group, thaumatin and an antifungal protein from tobacco, both 50% identical
in sequence to Jun a 3, as templates to build homology models for the allergen. The in-house programs EXDIS and FANTOM
were used to extract distance and dihedral angle constraints from the Protein Data Bank files and determine energy-
minimized structures. The mean backbone deviations for the energy-refined model structures from either of the templates is
1 Å, their conformational energies are low, and their stereochemical properties (determined with PROCHECK) are accept-
able. The circular dichroism spectrum of Jun a 3 is consistent with the postulated -sheet core. Tryptic fragments of Jun a
3 that reacted with IgE from allergic patients all mapped to one helical/loop surface of the models. The Jun a 3 models have
features common to aerosol allergens from completely different protein families, suggesting that tertiary structural elements
may mediate the triggering of an allergic response.
INTRODUCTION
Hypersensitivity to mountain cedar (Juniperus ashei, Cu-
pressaceae) pollen is a frequent cause of severe, seasonal
allergic disease (cedar pollinosis). Current treatment, which
has not been particularly successful, is limited to symptom-
atic therapy and attempts at hyposensitization by injection
of crude pollen extracts (Platts-Mills et al., 1998). Our
overall goal is to evaluate the structural basis of the allergic
immune response to mountain cedar pollen and to develop
new immunotherapeutic agents based on defined IgE-
binding epitopes. We isolated proteins from Texas moun-
tain cedar pollen that react with the IgE in patient sera and
cloned their related mRNAs. While one protein, Jun a 1
(Midoro-Horiuti et al., 1999a), was very similar to a protein
previously identified as the major allergen in Japanese cedar
pollen, we also discovered a second, novel allergen, Jun a 3
(Midoro-Horiuti et al., 2000). Jun a 3, a 30-kDa protein (199
residues), has high sequence identity with the PR-5 group of
plant pathogenesis-related proteins (PR proteins) that are
overexpressed when plants are subjected to stress conditions
or infected with pathogens (Linthorst, 1981). More recently,
an allergen (Pru a 2) believed to cause oral hypersensitivity
to cherry (Prunus avium, Prunoideae) (Inschlag et al., 1998)
was found to be a PR-5 group protein. The sequence of this
protein is 45% identical to that of Jun a 3. Many members
of the PR-5 family, including the PR-5D protein used here
for modeling Jun a 3, have antifungal properties; some may
also have antiviral activity, as they are produced in response
to viral infection in plants (Linthorst, 1981). Structural
knowledge of the epitopes responsible for allergenicity of
these proteins is essential for designing therapeutic agents
based on these proteins.
In this paper we describe experiments to define areas of
Jun a 3 that bind IgE and potentially induce allergic reac-
tions. A high-quality 3D structural model of the protein was
prepared by homology modeling and energy minimization.
The primarily -sheet secondary structure predicted by the
model was consistent with the circular dichroism (CD)
spectrum of the protein isolated from pollen. Tryptic frac-
tions of Jun a 3 were isolated by high-performance liquid
chromatography (HPLC) and tested for reactivity with IgE
in pooled patient sera, and positive fragments were identi-
fied by matrix-assisted laser desorption–mass spectrometry
(MALDI-MS) and N-terminal sequence analysis. Of the
four fragments detected in the HPLC fractions that reacted
with patient IgE in dot blotting, three mapped to the same
surface-exposed, helix/loop region in the model structure.
The fourth, IgE binding to which was not confirmed, was
located more internally in the same area. These data will be
used in designing studies to further delineate the allergenic
structures of this protein.
MATERIALS AND METHODS
Purification of Jun a 3 and isolation of
tryptic peptides
Native Jun a 3, a 30-kDa protein (199 residues), was purified as described
previously (Midoro-Horiuti et al., 2000). Briefly, defatted mountain cedar
pollen was extracted in 0.125 M ammonium bicarbonate (pH 8.0) at 4°C
for 48 h and precipitated with ammonium sulfate (40–80% of saturation
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fraction) (crude extract). Jun a 3 was isolated from the crude extract by
214TP510 (Vydac, Hesperia, CA) HPLC. The elution was performed with
a 30–50% gradient of acetonitrile in 0.1% trifluoroacetic acid.
Tryptic fragments of native Jun a 3 were purified by reverse-phase
HPLC (Midoro-Horiuti et al., 1999b). Briefly, 2 mg of Jun a 3 was reduced,
alkylated, and repurified, using reverse-phase HPLC on the Vydac column.
The Jun a 3 containing peak fraction 3 were lyophilized and redissolved in
0.1 M Tris-HCl (pH 8) containing 2 M urea and 0.01 M CaCl2, N-tosyl-
L-phenylalanine chloromethyl ketone (TPCK)-treated trypsin (enzyme/sub-
strate ratio  1:50; Promega, WI) was added, and the sample was incu-
bated for 17 h at 37°C. The tryptic peptides were separated by HPLC on a
218TP52 (Vydac) column, using a 0–45% gradient of acetonitrile in
0.08% trifluoroacetic acid. Fractions were vacuum evaporated, resus-
pended in water, and used for dot-blot immunostaining, N-terminal se-
quencing, and mass spectrometry.
Dot blot assay
IgE binding of tryptic peptides was analyzed by dot-blot immunostaining.
One microliter of each fraction from HPLC was dotted onto nitrocellulose.
The membranes were blocked with 10% (w/v) fat-free milk overnight and
incubated with a 1:4 dilution of pooled sera from cedar-hypersensitive
patients or normal controls overnight. After the membranes were washed
with Tween-TBS (0.05% Tween 20–Tris-buffered saline), they were in-
cubated with 1 g/ml of biotinylated anti-human IgE (Sigma, St. Louis,
MO), followed by incubation with 1:20,000 dilution of horseradish
peroxidase-streptavidin (Zymed, San Francisco, CA). The signal was de-
tected using enhanced chemoluminescence Western blot detection reagents
(Amersham, Piscataway, NJ). Human sera from allergic patients and pu-
rified Jun a 3 from pollen, dotted on the membrane served as positive
controls.
Mass spectrometry, N-terminal amino acid
sequence determination, and circular dichroism
Peptides reacting with IgE were analyzed by MALDI-MS (Perkin-Elmer-
Applied Biosystems (PE-ABI) Voyager instrument) at the Mass Spectrom-
etry Facility at the Louisiana State University Medical Center Core Lab-
oratories in New Orleans. Twenty percent of each HPLC fraction was used.
The N-terminal sequence of Jun a 3 and its tryptic peptides were deter-
mined using a PE-ABI Procise microsequencer. The CD spectrum was
measured on an Aviv spectrophotometer (model 62DS).
Homology modeling and structure refinement
A Blast (Altschul et al., 1990) search of the Protein Data Bank (PDB)
(Sussman et al., 1998) with the Jun a 3 sequence as probe yielded two
entries: pathogenesis-related protein 5d from tobacco (PDB file 1aun) and
thaumatin from African berry (PDB file 1thv). These proteins have, re-
spectively, 51.5% and 46.5% sequence identity with Jun a 3 and crystal
structures of resolution 1.80 Å and 1.75 Å, making them excellent refer-
ence templates for homology modeling. The homology models for Jun a 3
based on each of these templates, referred to as “aun” and “thv,” were
termed “Jun a 3aun” and “Jun a 3thv.”
Homology modeling of Jun a 3
The sequence of Jun a 3 was aligned with that of the template protein, with
the program CLUSTALW (Higgins et al., 1992) (Fig. 1). The program
EXDIS developed in our group (http://www.scsb.utmb.edu/FANTOM/
fm_home.html) was used to extract interatomic distance constraints and
dihedral angle constraints from the structure of the template. During this
process, short stretches corresponding to “gaps” or “loops” in the align-
FIGURE 1 CLUSTAL W sequence
alignments of Jun a 3 with the templates
aun (a) and thv (b) used for homology
modeling. Dashes indicate gaps: dots in-
dicate conservative substitutions.
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ment are left out, and constraints are extracted from the remaining “frag-
ments” of the protein (see Table 1 for the fragments of Jun a 3 used). For
a given atom, EXDIS selects a specified number of other atoms, chosen
randomly, and calculates distances to them. For Jun a 3, specifying 10
constraints per atom, a total of 11,457 distances were extracted from the
aun structure, and 11,542 from thv. Each distance was used as an upper and
a lower bound for that atom pair, by adding a “tolerance” value of 0.1 Å.
For dihedral angle constraints, EXDIS uses the following rule at each
aligned position: if the amino acids in Jun a 3 and the template are
identical, all dihedral angles are read from the template; if they differ, only
the backbone dihedral angles are read. Values of unknown dihedral angles
are assigned a starting value of 180°. These are converted to ranges by
adding 10° to  and 15° to the other torsion angles. For the two Jun a
3 models, 670 and 667 dihedral constraints were obtained from aun and
thv, respectively.
The program FANTOM (Schaumann et al., 1990) was then used with
the above constraints to minimize the conformational energy of the protein.
FANTOM uses the ECEPP/2 all-atom force field (Abe et al., 1984). The
total energy calculated is the sum of the conformational energy (electro-
static  hydrogen bond  Lennard-Jones  torsional energies) and the
constraint energy (weighted penalties for violations of dihedral angles 
upper  lower distance constraints). First, FANTOM constructs a starting
structure of the protein, taking standard geometries from a library and
dihedral angles from the template structure. The constraint energy is then
calculated, by penalizing deviations from the distance and dihedral angle
ranges that have already been set up. The total constraint energy is then
minimized, to produce a crude model. This first stage is referred to as
“regularization.” Both template structures have eight disulfide bridges, and
the corresponding residues are conserved in Jun a 3. The resulting disulfide
bonds in Jun a 3 are 9–198, 50–60, 65–71, 113–187, 118–171, 126–136,
140–149, and 150–158 (Jun a 3 numbers). There are two X-cis-Pro peptide
units in aun; the corresponding ones in Jun a 3 (Leu18-Pro19 and Val77-
Pro78) are modeled in cis configuration. In thv there is only one cis proline,
Pro79 (Fig. 1 b). Hence in the thv-based model, Pro78 is modeled as cis and
Pro19 as trans. The disulfide bridges and cis-Pro bonds were built at the
start of FANTOM runs.
In the next stage, the full energy function was applied and minimized.
A fourth-power energy function was used for distance constraints, which
added kT/2 to the total energy for a violation by 0.2 Å in the regularization
stage. This limit was raised in two steps to 1.0 Å by the end of the
minimization stage. The distance constraints to the template were thus
progressively relaxed. The dihedral angle constraint function added an
energy of 10.0*kT/2 for every 5° violation. The minimization was accom-
plished by the successive application of quasi-Newton and Newton- Raphson
minimizers as implemented in FANTOM (Schaumann et al., 1990).
Continuum electrostatics calculations
The 15 Asp, two Glu, 10 Lys, and four Arg residues of Jun a 3 and the
amino- (1) and carboxy- (1) terminal residues were considered
charged. All of the other residues (including His) were treated as neutral.
This charging scheme led to a total charge of 3 on the molecule. The
protein was assigned a dielectric constant of 2.0 and the surrounding
solvent, 80.0. For this system, the electrostatic potentials were calculated
by solving the Poisson-Boltzmann equation by the method of Nicholls and
Honig (1991), as implemented in the program MOLMOL (Koradi et al.,
1996). MOLMOL then displays the electric potential on the protein’s
contact surface (Richards, 1977).
RESULTS
Structural and energetic evaluation of the models
Fig. 2 is a stereo view of the two models, showing their
-carbon backbones superimposed according to the se-
quence alignments given in Fig. 1. We used the program
PROCHECK (Morris et al., 1992) to validate the models
based on stereochemical and geometric considerations (Ta-
ble 1). Only five residues were in the disallowed regions of
TABLE 1 Summary of Jun a 3 homology modeling
Property aun-based model thv-based model
Modeling details
Resolution of template structures (Å) 1.80 1.75
Sequence identity 103 (51.5%) 93 (46.5%)
Fragments used by EXDIS* 1–15, 24–84, 89–106,
115–152, 158–199
1–18, 23–87, 92–152,
158–199
Disulfide bridges (in both models) 10–199, 51–61, 66–72, 114–188, 119–172, 127–137, 141–150,
151–159
X-cis-Pro bonds in the model L19–P20, V78–P79 V78–P79
Number of residues/atoms in the calculation 200/3229 199/3210
Dihedral angle constraints from template 670 667
Upper/lower distance constraints from template 11457 11542
Analysis of the models
Backbone RMSD (Å) from template 0.633 0.954
Final van der Waals energy (kcal/mol) 1116 1067
Final constraint energy (kcal/mol) 389 933
Final conformational energy (kcal/mol) 1055 (5.3/residue) 1010 (5.1/residue)
Residues with disallowed backbone conformation† 5 2
Residues with  deviation 20° 0 1
Number of dihedral constraints violated by 5° 139 (21%) 153 (23%)
Upper distance constraints violated by 1 Å 112 (1%) 90 (1%)
Lower distance constraints violated by 1 Å 84 (1%) 56 (1%)
*See text for definitions and details.
†
From the Ramachandran map, as calculated by PROCHECK.
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the Ramachandran map for Jun a 3 aun, and two for Jun a
3 thv. There were no deviations in the peptide torsion angle
 above 20° for Jun a 3aun, and only one residue deviated
above that value in the thv-based model. Violations of the
distance and dihedral angle constraints in the final models
were within acceptable limits (Table 1). The conformational
and van der Waals energies were negative for both models.
These indicators show that both models were structurally
and energetically acceptable. The backbone root mean
square deviations (RMSDs) of the models from their re-
spective templates were low (0.63 Å (Jun a 3aun) and 0.95
Å (Jun a 3thv)), indicating a high degree of structural
similarity, as expected from their high degree of sequence
identity. In addition, 80% of the dihedral angles and
99% of the distance constraints extracted by EXDIS from
the template structures were conserved in the model struc-
tures.
Comparison of the two models
The backbone RMSD of the central structure of the models,
excluding the small loop regions where they differ because
FIGURE 3 Electrostatic potentials at the Jun a 3 surface for the aun model. Blue represents positive potentials and red represents negative potentials. (Left
and right) “Front” (corresponding to the orientation in Fig. 2) and “back” views of the molecule, respectively.
FIGURE 2 Stereo view of the aun-based and thv-based Jun a 3 models (thick and thin lines, respectively). Some residue numbers are marked. The
orientation is the same as in Fig. 7.
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of gapping in the alignment (19–20, 86–90, 107–112, 132–
134, 154–156, and 179–181; Fig. 2), is only 0.9 Å, showing
that the two models for Jun a 3 are very similar. The
segments where the gaps occur are in “loops” that connect
secondary structures, but not parts of secondary structures
themselves. The backbone RMSD between the two models
is 1.9 Å over the whole protein.
Fig. 3 shows the electrostatic potentials at the surface of
the Jun a 3 aun model; the labels indicate the approximate
location of the charged residues on the surface. The poten-
tials are (qualitatively) consistent with the location of the
charged residues. Also note that the amino- and carboxy-
terminal residues (Val1 and Pro200) are charged in our
calculations. A similar calculation based on the thv-based
model produced a very similar diagram (results not shown).
Spectral evidence for the secondary structure of
Jun a 3
The CD spectrum of Jun a 3 isolated from pollen (Fig. 4) is
very similar to that of birch pollen allergen Bet v 1 (Ferreira
et al., 1998), a predominantly -sheet protein, and the Pru a
1 allergen from cherry (Scheurer et al., 1999). Analysis of
this spectrum with the program CCA (Perczell et al., 1992;
Balasubramanian et al., 1998) indicated that the protein was
10% helical,28–32% -sheet, and the rest random coil,
with a 4% margin of error. This is consistent with our
model, where 27/198 (13.6%) amino acids are in -helices
and 59/198 (29.8%) in a -sheet conformation.
IgE-reactive tryptic peptides
The products of trypsin degradation of Jun a 3 were sepa-
rated by HPLC (Fig. 5 A), and the fractions were tested for
reactivity with pooled patient serum IgE by dot blotting
(Fig. 5 B). The composition of fractions that showed high
reactivity with IgE from cedar hypersensitive patients (50,
55, 56, 62, and 65) were analyzed by mass spectrometry
(Fig. 6 and Table 2) for peptides specific for Jun a 3.
Peptides 120–131 (fractions 62 and 65), 132–145 (fraction
56), and 152–165 (fractions 50 and 55) were determined to
be IgE epitopes. A fourth peptide, 169–179, was also iden-
tified in the IgE-positive HPLC fraction 55, but not as the
sole Jun a 3-derived component of any fraction. Thus IgE
binding could not be conclusively attributed to this peptide.
These results were partially confirmed by a separate
experiment. Half of the original tryptic digest was fraction-
ated similarly on HPLC, the fractions were checked for
reactivity with patient IgE, and positive fractions were an-
alyzed by N-terminal amino acid sequencing (data not
shown). While the amount of protein was limiting, peptide
152–165 was detected as the sole peptide in a fraction with
which the IgE in patient sera reacted.
Location of epitopes on the protein surface
Fig. 7 is a ribbon and “neon” rendering of Jun a 3 depicting
the three positively identified IgE epitopes (red, residues
120–131; gold, 132–145; and blue, 152–165). Peptide 169–
FIGURE 4 CD spectrum of Jun a 3 isolated from pollen. The spectrum
was collected at room temperature; the protein concentration was 0.5
mg/ml (A280 	 0.5) in phosphate-buffered saline.
FIGURE 5 Tryptic fragments in fractions of Jun a 3 that react with
patient IgE. A tryptic digest of Jun a 3 was fractionated by HPLC (A) as
described in Materials and Methods, and the fractions were analyzed by
immunodotspotting (B). The numbers in B correspond to the indicated
fraction in A. The two positive controls are 1 g of intact Jun a 3 from
pollen and 1 l of patient serum (1:100 dilution) for total IgE, applied with
the samples before the membrane was blocked.
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179, which was also identified in fraction 55, is located
behind these peptides in an area of lower solvent exposure.
The orientation of the molecule is the same as in Figs. 2 and
3. Note that the epitopes are on one face of the protein,
accessible for interaction with other macromolecules, such
as immunoglobulins. This area maps to the front view of the
electrostatic surface in Fig. 3, which indicates that the
putative interaction surface is an extensive hydrophobic
patch encircled by the charged side chains of Glu129, Lys144,
Arg151, Asp146, Lys179, Asp156, and Lys165. We propose that
this large, solvent-exposed, hydrophobic area surrounded by
charged residues contributes to both the binding affinity and
specificity of the interaction with IgE.
DISCUSSION
Jun a 3 is among the first pollen allergens to be character-
ized as a PR protein, based on sequence identity with
members of this family of plant proteins, the expression of
which is induced by stress, osmotic shock drought, freezing
temperature, infection, or ultraviolet B light. As there were
high-resolution crystal structures for two proteins with
40% sequence identity with Jun a 3 (Fig. 1), we were able
to prepare detailed model structures, using our in-house
programs EXDIS and FANTOM (Fig. 2). As Table 1 shows,
few of the12,000 angle and distance constraints extracted
from either template were violated in the model structures,
and the structures are stereochemically acceptable. These
model structures are the first reported for this family of
allergens and will be deposited in the PDB.
Similarities between the Jun a 3 models and the
structures of other known allergens
Allergenic proteins identified to date can be grouped into
discrete families based on sequence similarity (Stewart and
FIGURE 6 Mass spectrometry of HPLC fractions from the tryptic digest of Jun a 3 that bound IgE from pooled patient sera (Fig. 5). The molecular
weights of the peptides from Jun a 3 detected in each fraction (fraction number in parentheses) were 1615.66 (50); 1326.26 and 1617.58 (55); 1426.19 (56);
1315.62 (62); and 1316.02 (65). The peaks at 1383.33 (55); 915.46 and 1169.5 (62); and 2411.29, 2468.64, and 2525.53 (65) probably resulted from trace
contaminants.
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Thompson, 1996; Liebers et al., 1996). The new allergens of
the PR-5 family, including Jun a 3, share no apparent sequence
identity with birch pollen allergen Bet v 1 (Gajhede et al.,
1996) or any of the other aerosol allergens for which a 3D
structure is available in the PDB. However, as Fig. 8 illustrates,
the model has features in common with the larger allergen
proteins, the structures of which are available in the PDB
(Rouvinen et al., 1999; Arruda et al., 1995). These proteins
have a -sheet core and flexible loop regions on the surface.
Although there is some helical character to these loop regions,
several of the allergens contain no helix at all. According to
SCOP, the structural classification for proteins (Murzin et al.,
1995), Phl p 2, Der f 2, Der p 2, Bos d 2, Equ c 1, and mMUP
belong to the structural class “all ,” and Bet v 1 and Bet v 2
to “” proteins. Amb t 5 consists of a three-stranded
antiparallel -sheet with a short -helix packed against it. Thus
the overall features of the known structures are similar, despite
their lack of sequence similarity.
The structural similarity among these allergens is further
emphasized by the CD spectra of Jun a 3 (Fig. 4), which
closely resembles that of recombinant Bet v 1 (Ferreira et
al., 1998), and the Bet v 1 homologue from cherry, Pru a 1
(Scheurer et al., 1999).
Allergenic epitopes are in a helix-loop region on
one face of Jun a 3
The tryptic fragments of Jun a 3 that reacted with patient
IgE (Figs. 5 and 6) sufficiently to be detected in the dot-blot
assay mapped to one surface-exposed helical/loop region of
the model (Fig. 7). The location of these epitopes is con-
sistent with that reported for other aeroallergens. The IgE-
binding epitopes in birch pollen profilin (Fedorov et al.,
1997a) are clustered at the N and C termini. Both termini are
loop areas, proximal to the top and sides of the -sheet core
of the protein. Deletions of loop regions between either
Cys21 and Cys27 or Cys73 and Cys78 in the mite allergen Der
p 2 decreased the binding to IgE from certain patient sera by
up to 1000 times (Hakkaart et al., 1998). Both of these areas
map to surface loops peripheral to the central -barrel core
in the NMR structure of Der p 2 (Mueller et al., 1998).
Mutating a serine residue in Bet v 1 (or its close relative Pru
a 1, which should have a similar structure) at the end of a
FIGURE 7 The IgE epitopes of Jun a 3 identified by trypsin hydrolysis
and dot blotting are on one surface of the model. The backbone of the
aun-based model is shown in gray; all nonhydrogen atoms are shown for
the three epitopes in red (residues 120–131), gold (132–145), and blue
(152–165). The orientation of the model is the same as in Fig. 2.
TABLE 2 Anticipated tryptic fragments of Jun a 3 in order of decreasing size, their calculated mass, and identification in HPLC
fractions reacting positively with patient IgE in dot-blot assay
Sequence of the peptide Residue numbers
Calculated
molecular mass*
HPLC fractions
reacting with patient
IgE†
GSCQTGDCGGQLSCTVSGAVPATL 58–119 6613.95
EYTQSDQDYYDVSLVDGFNIPLAI
PTNAQCTAPACK
DDTATFACASGTDYSIVFCP 180–199 2197.90
LDQGQTWTVNLAAGTASAR 25–43 1995.99
NQCGYTVWAAGLPGGGK 7–23 1735.82
NAYVDNCPATNYSK 152–165 1616.70 50:1615.66; 55:1617.58
VDGGCNSACNVFK 132–144 1427.60 56:1426.19
NQCPQAYSYAK 169–179 1329.59 55:1326.26
ADINAVCPSELK 120–131 1316.65 62:1315.62; 65:1316.02
TGCTFDASGK 48–57 1043.45
TDQYCCR 145–151 1002.37
FWGR 44–47 565.29
FDIK 3–6 522.29
*Accounts for reduction and alkylation.
†See Fig. 6 for the mass spectra.
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loop immediately proximal to the -sheet core, decreases
IgE reactivity by a factor of 10–1000-fold (Scheurer et al.,
1999). Mutations that reduced IgG binding were all in one
loop of Amb t 5 (Rafner et al., 1998). Although two of the
tryptic fragments we identified as IgE epitopes are long
enough to assume some secondary structure after immobi-
lization on the dot-blotting membrane surface, our analysis
can identify only continuous epitopes. Judging from studies
of other allergens (Collins et al., 1996; Mueller et al., 1998;
Ichikawa et al., 1998; der Val et al., 1999; Engel et al.,
1997), Jun a 3 may have areas of reactivity with IgE that are
dependent on an intact 3D structure. For example, six amino
acids, widely separated in the crystal structure of Bet v 1,
were identified by comparative analysis of the aligned se-
quences of Bet v 1 and related proteins. Mutations at these
positions reduced reactivity with patient IgE and skin-prick
test responses (Ferreira et al., 1998). The effects of the
mutations were, for the most part, cumulative.
In conclusion, our model structure of the novel allergen
Jun a 3 shares many features with those of other allergens.
The IgE epitopes mapped to one side of this structure, in a
location similar to that seen for other aeroallergens. More
detailed understanding of the similarities between the 3D-
structures of allergens and their epitopes may provide an
approach to the prediction of allergenicity in other proteins
and design strategies for the therapeutic control of allergic
responses (Valenta et al., 1998).
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